Interestingly, targeting the TREM2-APOE pathway can restore the homeostatic phenotype of microglia in amyotrophic lateral sclerosis (ALS) and AD mice models, and prevented neuronal loss in an acute neurodegeneration model (Krasemann et al., 2017). Here, APOE is linked to Alzheimer disease.